Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu (Q40105474)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu |
scientific article |
Statements
1 reference
Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu (English)
1 reference
Marie P Piechocki
1 reference
George H Yoo
1 reference
Susan K Dibbley
1 reference
Fulvio Lonardo
1 reference
1 July 2007
1 reference
1 reference
6825-6843
1 reference
Identifiers
1 reference